AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16036030 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol tartrate (target dosage 50 mg twice daily)
Number of subjects: 3029
Study 12509205 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonspatial sequence learning (implicit learning)
Number of subjects: 0
Study 12509205 — intervention group
Group type: COMPARATOR
Intervention: Stimulus distance (3 cm, 6 cm, 12 cm, or 22 cm)
Number of subjects: 0
Study 12509205 — intervention group
Group type: EXPERIMENTAL
Intervention: Subgroup of implicit learners
Number of subjects: 0
Study 10219066 — intervention group
Group type: EXPERIMENTAL
Intervention: D-chiro-inositol (1200 mg once daily for 6-8 weeks)
Number of subjects: 44
Study 10219066 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 7484276 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise for 18 months
Number of subjects: 56
Study 7484276 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 56
Study 2298863 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03 mg/kg rhGH
Number of subjects: 16
Study 2298863 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.06 mg/kg rhGH
Number of subjects: 16
Study 2298863 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12 mg/kg rhGH
Number of subjects: 16
Study 2298863 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH
Number of subjects: 16
Study 7191647 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.75% in 8.25% dextrose, 7.5 mg
Number of subjects: 435
Study 7191647 — intervention group
Group type: COMPARATOR
Intervention: Tetracaine, 7.5 mg
Number of subjects: 435
Study 7191647 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.75% in 8.25% dextrose, 12 mg
Number of subjects: 435
Study 7191647 — intervention group
Group type: COMPARATOR
Intervention: Tetracaine, 12 mg
Number of subjects: 435
Study 7191647 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine added to local anesthetic solution
Number of subjects: 435
Study 7191647 — intervention group
Group type: COMPARATOR
Intervention: Tetracaine
Number of subjects: 435
Study 31952323 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrotherapy intervention
Number of subjects: 8
Study 30359438 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g lactulose
Number of subjects: 32
Study 30359438 — intervention group
Group type: COMPARATOR
Intervention: 50 g sucrose (control)
Number of subjects: 32
Study 27604995 — intervention group
Group type: EXPERIMENTAL
Intervention: IMRT
Number of subjects: 80
Study 27604995 — intervention group
Group type: COMPARATOR
Intervention: 3DRT
Number of subjects: 80
Study 24872554 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued recall paradigm with visual psychophysics and functional neuroimaging
Number of subjects: 0
Study 22856247 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient fortified biscuits (100 g providing RDA levels of vitamin A, iron, folic acid, vitamin C, and iodine)
Number of subjects: 107
Study 22856247 — intervention group
Group type: COMPARATOR
Intervention: Control biscuits (100 g providing 497 kcal and 11.36 g of protein)
Number of subjects: 107
Study 20399523 — intervention group
Group type: EXPERIMENTAL
Intervention: DAFNE structured education
Number of subjects: 104
Study 18560697 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (3 mg elemental zinc per day as zinc sulphate)
Number of subjects: 31
Study 18560697 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 18560697 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 31
Study 16008116 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg EGCG
Number of subjects: 30
Study 16008116 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg EGCG
Number of subjects: 30
Study 16008116 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 12447028 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual cognitive-behavioral therapy (CBT)
Number of subjects: 78
Study 12447028 — intervention group
Group type: COMPARATOR
Intervention: Group cognitive-behavioral therapy (CBT)
Number of subjects: 78
Study 11034937 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg testosterone daily by transdermal patch
Number of subjects: 46
Study 11034937 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 46
Study 8679347 — intervention group
Group type: EXPERIMENTAL
Intervention: Cricoid pressure (30 N) applied with neck support
Number of subjects: 50
Study 8679347 — intervention group
Group type: EXPERIMENTAL
Intervention: Cricoid pressure (30 N) applied without neck support
Number of subjects: 50
Study 2054265 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium hydroxide (850 mg)
Number of subjects: 6
Study 2054265 — intervention group
Group type: COMPARATOR
Intervention: Water (150 ml)
Number of subjects: 6
Study 6342562 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine hydrochloride
Number of subjects: 0
Study 6342562 — intervention group
Group type: COMPARATOR
Intervention: Clorgyline hydrochloride
Number of subjects: 0
Study 6342562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31283831 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory impairment (vision, hearing, dual)
Number of subjects: 213
Study 31283831 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater social engagement
Number of subjects: 213
Study 29216745 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation
Number of subjects: 110
Study 29216745 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation then walk
Number of subjects: 110
Study 29216745 — intervention group
Group type: EXPERIMENTAL
Intervention: Walk then meditation
Number of subjects: 110
Study 29216745 — intervention group
Group type: COMPARATOR
Intervention: Walk
Number of subjects: 110
Study 29216745 — intervention group
Group type: COMPARATOR
Intervention: Control (inactive)
Number of subjects: 110
Study 27077673 — intervention group
Group type: EXPERIMENTAL
Intervention: PEGylated‐interferonα2b (1.5 μg/kg/week) + ribavirin (800‐1400 mg/day) + boceprevir (800 mg TID)
Number of subjects: 64
Study 24320105 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical virgin coconut oil (VCO)
Number of subjects: 117
Study 24320105 — intervention group
Group type: COMPARATOR
Intervention: Mineral oil
Number of subjects: 117
Study 22909899 — intervention group
Group type: EXPERIMENTAL
Intervention: Oseltamivir-zanamivir bitherapy (O+Z)
Number of subjects: 24
Study 22909899 — intervention group
Group type: COMPARATOR
Intervention: Oseltamivir monotherapy (O)
Number of subjects: 24
Study 21256403 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrice A (1450 ppm fluoride as NaF, 50000 ppm KNO3) plus 450 ppm fluoride (NaF) rinse
Number of subjects: 36
Study 21256403 — intervention group
Group type: COMPARATOR
Intervention: Dentifrice A plus sterile water rinse
Number of subjects: 36
Study 21256403 — intervention group
Group type: COMPARATOR
Intervention: Dentifrice B (fluoride-free Dentifrice A) plus sterile water rinse
Number of subjects: 36
Study 21256403 — intervention group
Group type: COMPARATOR
Intervention: Dentifrice B plus 450 ppm fluoride (NaF) rinse
Number of subjects: 36
Study 21256403 — intervention group
Group type: COMPARATOR
Intervention: Dentifrice C (1000 ppm fluorine as sodium monofluorophosphate, 450 ppm fluoride as NaF) plus sterile water rinse
Number of subjects: 36
Study 18076252 — intervention group
Group type: EXPERIMENTAL
Intervention: Raisins
Number of subjects: 8
Study 18076252 — intervention group
Group type: COMPARATOR
Intervention: Sports Gel
Number of subjects: 8
Study 16123554 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep sclerectomy with low-dosage mitomycin C (DSMMC)
Number of subjects: 40
Study 16123554 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy with low-dosage mitomycin C (TPMMC)
Number of subjects: 40
Study 16123554 — intervention group
Group type: COMPARATOR
Intervention: TPMMC
Number of subjects: 40
Study 11854873 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural anesthesia with general anesthesia (epidural group)
Number of subjects: 90
Study 11854873 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia with immediate extubation (extubated group)
Number of subjects: 90
Study 11854873 — intervention group
Group type: COMPARATOR
Intervention: General anesthesia with postoperative ventilation (intubated group)
Number of subjects: 90
Study 10400005 — intervention group
Group type: EXPERIMENTAL
Intervention: Nesiritide (0.015, 0.03, and 0.06 microg/kg/min) administered by continuous intravenous infusion over 24 h
Number of subjects: 103
Study 10400005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study 7547820 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg temazepam elixir
Number of subjects: 22
Study 7547820 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg temazepam elixir
Number of subjects: 22
Study 8248349 — intervention group
Group type: EXPERIMENTAL
Intervention: RU 486 (10 mg/kg)
Number of subjects: 0
Study 8248349 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3827169 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical internal urethrotomy without catheter
Number of subjects: 54
Study 3827169 — intervention group
Group type: COMPARATOR
Intervention: Optical internal urethrotomy with catheter for one day
Number of subjects: 54
Study 30249417 — intervention group
Group type: EXPERIMENTAL
Intervention: Active neurostimulation
Number of subjects: 25
Study 30249417 — intervention group
Group type: COMPARATOR
Intervention: Sham neurostimulation
Number of subjects: 25
Study 30249417 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups during open-label extension
Number of subjects: 25
Study 26750741 — intervention group
Group type: EXPERIMENTAL
Intervention: CRE readmission score (derived from predictors)
Number of subjects: 168
Study 26750741 — intervention group
Group type: EXPERIMENTAL
Intervention: CRE readmission score (validation set)
Number of subjects: 168
Study 26750741 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictors of persistent CRE carriage
Number of subjects: 168
Study 26750741 — intervention group
Group type: EXPERIMENTAL
Intervention: C statistics for the model and score
Number of subjects: 168
Study 26482090 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 1026
Study 26482090 — intervention group
Group type: COMPARATOR
Intervention: Control (no BI)
Number of subjects: 1026
Study 23527884 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) of the subcallosal cingulate (SCC) with longer pulse widths (270-450 μs)
Number of subjects: 4
Study 23527884 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) of the subcallosal cingulate (SCC) with frequency changes
Number of subjects: 4
Study 23527884 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label therapy after optimization
Number of subjects: 4
Study 21228310 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1000 mg twice daily for 6 months
Number of subjects: 100
Study 21228310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 19149330 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral program
Number of subjects: 174
Study 19149330 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 174
Study 16570894 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 mg risedronate once weekly for 6 months
Number of subjects: 24
Study 16570894 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 24
Study 12756640 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic cephalexin and ethyl lactate shampoo therapy
Number of subjects: 20
Study 12756640 — intervention group
Group type: COMPARATOR
Intervention: Systemic cephalexin therapy
Number of subjects: 20
Study 10683351 — intervention group
Group type: EXPERIMENTAL
Intervention: Irrigated-tip catheter
Number of subjects: 50
Study 10683351 — intervention group
Group type: COMPARATOR
Intervention: Conventional catheter
Number of subjects: 50
Study 9510449 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary treatment for phenylketonuria (PKU)
Number of subjects: 14
Study 9510449 — intervention group
Group type: COMPARATOR
Intervention: Healthy gender‐, age‐, weight‐ and height‐matched controls
Number of subjects: 14
Study 7835362 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol CR 200 mg once a day
Number of subjects: 18
Study 7835362 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg once a day
Number of subjects: 18
Study 7835362 — intervention group
Group type: COMPARATOR
Intervention: Placebo once a day
Number of subjects: 18
Study 3046298 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fat reduction
Number of subjects: 57
Study 29136336 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 100 mg single oral dose
Number of subjects: 46
Study 26871201 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg pregabalin (PGL)
Number of subjects: 100
Study 26871201 — intervention group
Group type: COMPARATOR
Intervention: 500 mg starch (placebo)
Number of subjects: 100
Study 24062546 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal magnesium sulfate (MgSO4) - initial dose 4 g, maintained at 1 g/h up to maximum of 24 h
Number of subjects: 72
Study 24062546 — intervention group
Group type: COMPARATOR
Intervention: Control group (full-term pregnancy)
Number of subjects: 72
Study 24062546 — intervention group
Group type: COMPARATOR
Intervention: Premature pregnancy without MgSO4
Number of subjects: 72
Study 22964926 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide-formoterol combination (400 µg budesonide and 12 µg formoterol)
Number of subjects: 181
Study 22964926 — intervention group
Group type: COMPARATOR
Intervention: Budesonide alone (400 µg)
Number of subjects: 181
Study 20350345 — intervention group
Group type: EXPERIMENTAL
Intervention: Free Fruit 08
Number of subjects: 1488
Study 20350345 — intervention group
Group type: EXPERIMENTAL
Intervention: Subscription 08
Number of subjects: 1488
Study 20350345 — intervention group
Group type: COMPARATOR
Intervention: No Programme 08
Number of subjects: 1488
Study 20350345 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1488
Study 19029279 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 24
Study 19029279 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal needling
Number of subjects: 24
Study 19029279 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 24
Study 15860348 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum BDNF levels in depressed patients
Number of subjects: 43
Study 15860348 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma BDNF levels in depressed patients
Number of subjects: 43
Study 15860348 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole blood BDNF levels in depressed patients
Number of subjects: 43
Study 15860348 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum/Blood BDNF ratio in patients with major depression
Number of subjects: 43
Study 15860348 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma PF4 levels in depressed subjects
Number of subjects: 43
Study 15860348 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum PF4 levels in depressed subjects
Number of subjects: 43
Study 12412210 — intervention group
Group type: EXPERIMENTAL
Intervention: sulfasalazine
Number of subjects: 33
Study 12412210 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 33
Study 8810809 — intervention group
Group type: EXPERIMENTAL
Intervention: 13C-urea (50 mg)
Number of subjects: 39
Study 8810809 — intervention group
Group type: EXPERIMENTAL
Intervention: 13C-urea (100 mg)
Number of subjects: 39
Study 8810809 — intervention group
Group type: EXPERIMENTAL
Intervention: 13C-urea (150 mg)
Number of subjects: 39
Study 8810809 — intervention group
Group type: EXPERIMENTAL
Intervention: 13C-urea (all doses)
Number of subjects: 39
Study 2680084 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg daily for four weeks
Number of subjects: 52
Study 2680084 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 1191783 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheme I: 100 rad 3 times a day, 5 days a week, total tumor dose of 8,400 rad, with 2 weeks of rest in the middle of treatment.
Number of subjects: 45
Study 1191783 — intervention group
Group type: COMPARATOR
Intervention: Scheme II: 200 rad once a day, 5 days a week, total tumor dose of 6,400 rad, with 2 weeks of rest in the middle of treatment.
Number of subjects: 45
Study 30935934 — intervention group
Group type: EXPERIMENTAL
Intervention: Articles tweeted
Number of subjects: 2361
Study 30935934 — intervention group
Group type: EXPERIMENTAL
Intervention: Facebook posts
Number of subjects: 2361
Study 30935934 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of Mendeley readers
Number of subjects: 2361
Study 30935934 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of Tweeters
Number of subjects: 2361
Study 30935934 — intervention group
Group type: EXPERIMENTAL
Intervention: F1000 reviews
Number of subjects: 2361
Study 30935934 — intervention group
Group type: EXPERIMENTAL
Intervention: Policy documents
Number of subjects: 2361
Study 29192535 — intervention group
Group type: EXPERIMENTAL
Intervention: Prism Adaptation (PA)
Number of subjects: 70
Study 29192535 — intervention group
Group type: COMPARATOR
Intervention: Sham Adaptation (SA)
Number of subjects: 70
Study 25223324 — intervention group
Group type: EXPERIMENTAL
Intervention: Pencil Beam (PB) algorithm
Number of subjects: 45
Study 25223324 — intervention group
Group type: EXPERIMENTAL
Intervention: X-ray Voxel Monte Carlo (MC) algorithm
Number of subjects: 45
Study 25223324 — intervention group
Group type: EXPERIMENTAL
Intervention: Pencil Beam (PB) algorithm with hypoxic cells considered
Number of subjects: 45
Study 25223324 — intervention group
Group type: EXPERIMENTAL
Intervention: X-ray Voxel Monte Carlo (MC) algorithm with hypoxic cells considered
Number of subjects: 45
Study 25223324 — intervention group
Group type: EXPERIMENTAL
Intervention: Renormalized plans for oxic cells
Number of subjects: 45
Study 25223324 — intervention group
Group type: EXPERIMENTAL
Intervention: Renormalized plans for hypoxic cells
Number of subjects: 45
Study 23829265 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily swimming lessons (45 minutes) in a chlorinated pool for 4 weeks
Number of subjects: 89
Study 23829265 — intervention group
Group type: COMPARATOR
Intervention: Non-swimming group
Number of subjects: 89
Study 21351116 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon alpha 2a with ribavirin (PEG 2a + RV)
Number of subjects: 114
Study 21351116 — intervention group
Group type: COMPARATOR
Intervention: Peginterferon alpha 2a with placebo (PEG 2a + PL)
Number of subjects: 114
Study 19647824 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin treatment
Number of subjects: 43
Study 17384382 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactated Ringer's solution (LR)
Number of subjects: 28
Study 17384382 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (NS)
Number of subjects: 28
Study 14695860 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical assessment by a geriatrician or old age psychiatrist
Number of subjects: 256
Study 14695860 — intervention group
Group type: COMPARATOR
Intervention: Usual care management assessment
Number of subjects: 256
Study 11802021 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar scissors tonsillectomy
Number of subjects: 200
Study 11802021 — intervention group
Group type: COMPARATOR
Intervention: Cold dissection tonsillectomy
Number of subjects: 200
Study 11802021 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 200
Study 9495396 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine 0.1 mg/kg
Number of subjects: 90
Study 9495396 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine 0.2 mg/kg
Number of subjects: 90
Study 9495396 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 90
Study 7846922 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotetan
Number of subjects: 114
Study 7846922 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin/Amikacin
Number of subjects: 114
Study 2463406 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/kg diltiazem daily for 1 year
Number of subjects: 13
Study 2463406 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 2463406 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem therapy continued after 1 year
Number of subjects: 13
Study 322547 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (2 mg/ml) administered by microdrip at an average rate of 10 ml/min
Number of subjects: 40
Study 322547 — intervention group
Group type: COMPARATOR
Intervention: Innovar (0.1 ml/ml) administered by microdrip at an average rate of 10 ml/min
Number of subjects: 40
Study 31397904 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 0
Study 31397904 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28837725 — intervention group
Group type: EXPERIMENTAL
Intervention: Drain removal threshold of less than 30 mL during a 24-hour period
Number of subjects: 53
Study 28837725 — intervention group
Group type: COMPARATOR
Intervention: Drain removal threshold of less than 100 mL during a 24-hour period
Number of subjects: 53
Study 23826985 — intervention group
Group type: EXPERIMENTAL
Intervention: Media Smart
Number of subjects: 51
Study 23826985 — intervention group
Group type: COMPARATOR
Intervention: Control (usual lessons)
Number of subjects: 51
Study 24126948 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple courses of antenatal corticosteroid therapy
Number of subjects: 1724
Study 24126948 — intervention group
Group type: COMPARATOR
Intervention: Single course of antenatal corticosteroid therapy
Number of subjects: 1724
Study 23094556 — intervention group
Group type: EXPERIMENTAL
Intervention: Lip bumper
Number of subjects: 0
Study 23094556 — intervention group
Group type: COMPARATOR
Intervention: Headgear
Number of subjects: 0
Study 20018421 — intervention group
Group type: EXPERIMENTAL
Intervention: Placental drainage
Number of subjects: 36
Study 20018421 — intervention group
Group type: COMPARATOR
Intervention: Clamped cord
Number of subjects: 36
Study 20018421 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 36
Study 17192165 — intervention group
Group type: EXPERIMENTAL
Intervention: Rasburicase
Number of subjects: 0